Free Trial
TSE:VHI

Vitalhub (VHI) Stock Price, News & Analysis

Vitalhub logo
C$9.56 -0.10 (-1.04%)
As of 04:00 PM Eastern

About Vitalhub Stock (TSE:VHI)

Key Stats

Today's Range
C$8.94
C$9.68
50-Day Range
C$9.56
C$11.99
52-Week Range
C$5.38
C$12.09
Volume
507,727 shs
Average Volume
123,913 shs
Market Capitalization
C$517.12 million
P/E Ratio
155.49
Dividend Yield
N/A
Price Target
C$11.60
Consensus Rating
Buy

Company Overview

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions. Vitalhub Corp. was founded in 2010 and is based in Toronto, Canada.

Vitalhub Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

VHI MarketRank™: 

Vitalhub scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vitalhub has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vitalhub has only been the subject of 2 research reports in the past 90 days.

  • Read more about Vitalhub's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vitalhub is 155.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vitalhub is 155.49, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.89.

  • Price to Earnings Growth Ratio

    Vitalhub has a PEG Ratio of 1.18. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Vitalhub has a P/B Ratio of 3.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for VHI.
  • Dividend Yield

    Vitalhub does not currently pay a dividend.

  • Dividend Growth

    Vitalhub does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for VHI.
  • News Sentiment

    Vitalhub has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vitalhub this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Vitalhub insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.57% of the stock of Vitalhub is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 32.40% of the stock of Vitalhub is held by institutions.

  • Read more about Vitalhub's insider trading history.
Receive VHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitalhub and its competitors with MarketBeat's FREE daily newsletter.

VHI Stock News Headlines

Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
Vitalhub (VHI) Gets a Buy from Scotiabank
TD Securities Remains a Buy on Vitalhub (VHI)
See More Headlines

VHI Stock Analysis - Frequently Asked Questions

Vitalhub's stock was trading at C$11.27 at the beginning of 2025. Since then, VHI shares have decreased by 15.2% and is now trading at C$9.56.
View the best growth stocks for 2025 here
.

Shares of VHI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vitalhub investors own include AST SpaceMobile (ASTS), Intel (INTC), Tempus AI (TEM), Recursion Pharmaceuticals (RXRX), Advanced Micro Devices (AMD), Broadcom (AVGO) and Genius Sports (GENI).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Health Information Services
Sub-Industry
Chemicals
Current Symbol
TSE:VHI
CIK
N/A
Fax
N/A
Employees
2,250
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$11.60
High Stock Price Target
C$14.00
Low Stock Price Target
C$8.00
Potential Upside/Downside
+20.2%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
156.95
Forward P/E Ratio
42.02
P/E Growth
1.18
Net Income
C$3.35 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$65.49 million
Price / Cash Flow
N/A
Book Value
C$2.53 per share
Price / Book
3.82

Miscellaneous

Free Float
N/A
Market Cap
C$521.99 million
Optionable
Not Optionable
Beta
1.26
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (TSE:VHI) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners